BIO-key International, Inc.
BKYI
$0.79
$0.0212.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -19.88% | 18.03% | -40.83% | -0.12% | 3.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.88% | 18.03% | -40.83% | -0.12% | 3.79% |
| Cost of Revenue | -86.34% | -68.50% | -83.67% | -77.31% | 95.10% |
| Gross Profit | 1,356.44% | 393.30% | 172.30% | 117.90% | -112.34% |
| SG&A Expenses | -14.90% | -9.48% | -9.39% | -7.70% | -28.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.99% | -27.96% | -35.10% | -31.76% | -6.54% |
| Operating Income | 53.46% | 70.47% | 30.46% | 71.06% | 12.39% |
| Income Before Tax | 46.88% | 59.79% | 32.78% | 69.77% | 61.09% |
| Income Tax Expenses | 91.69% | -- | -- | -- | -1,256.86% |
| Earnings from Continuing Operations | 41.65% | 59.79% | 36.44% | 69.77% | 65.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.65% | 59.79% | 36.44% | 69.77% | 65.05% |
| EBIT | 53.46% | 70.47% | 30.46% | 71.06% | 12.39% |
| EBITDA | 54.04% | 74.71% | 31.97% | 75.53% | 15.49% |
| EPS Basic | 89.77% | 87.86% | 78.72% | 91.00% | 69.93% |
| Normalized Basic EPS | 91.19% | 88.87% | 77.08% | 91.70% | 43.48% |
| EPS Diluted | 89.77% | 87.86% | 78.72% | 91.00% | 69.93% |
| Normalized Diluted EPS | 91.19% | 88.87% | 77.08% | 91.70% | 43.48% |
| Average Basic Shares Outstanding | 470.50% | 231.06% | 198.67% | 235.96% | 16.25% |
| Average Diluted Shares Outstanding | 470.50% | 231.06% | 198.67% | 235.96% | 16.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |